Research Article

Sensitivity and Specificity of the ECAS in Parkinson’s Disease and Progressive Supranuclear Palsy

Table 3

ECAS scores of the participants.

PSP patientsPD patientsControlsF (df)
Mean (SD)RangeMean (SD)RangeMean (SD)Range

Total (max. 136)85.09 (24.46)54–126109.87 (13.52)78–126120.61 (7.06)100–13217.44 (2, 22.09)a<0.001
Executive function (max. 48)29.27 (13.27)9–4636.93 (6.05)19–4442.11 (3.49)33–4812.56 (2, 22.22)a<0.001
Language (max. 28)23.18 (5.06)15–2826.67 (2.11)19–2827.50 (0.80)25–285.76 (2, 21.01)a<0.001
Fluency (max. 24)8.18 (8.74)0–2218.73 (4.83)6–2420.74 (2.39)12–2412.37 (2, 21.91)a<0.001
Memory (max. 24)10.27 (6.90)0–2015.67 (4.25)3–2218.39 (2.53)13–2310.85 (2, 22.76)a<0.001
Visuospatial (max. 12)11.09 (1.87)6–1211.47 (1.04)8–1211.87 (0.67)8–122.33 (2, 22.86)a0.066

aWelch’s adjusted F ratio.